Målet med AI-Mind er å utvikle smarte diagnostiske verktøy for å forutsi, på et tidlig stadium, hvem som er i faresonen for å utvikle demens. Studien vil finne sted i Norge, Finland, Italia og Spania, og vil involvere totalt 1000 deltakere.

The AI-Mind project aims to ease the burden of dementia by creating innovative, AI-driven tools that assist healthcare professionals in predicting dementia risks in patients affected by mild cognitive impairment (MCI).

At the heart of AI-Mind is our research study, that Takes place in Norway, Finland, Italy and Spain and will involve 1,000 participants. Helps to develop and validate artificial intelligence (AI) based tools to predict who is likely to develop dementia.

L’obiettivo di AI-Mind è quello di sviluppare strumenti diagnostici intelligenti per prevedere, in una fase iniziale, chi ha probabilità di sviluppare la demenza. Lo studio si svolgerà in Norvegia, Finlandia, Italia e Spagna, e coinvolgerà un totale di 1.000 partecipanti.

The aim of AI-Mind is to develop smart diagnostic tools to predict, at an early stage, who is likely to develop dementia. The study will take place in Norway, Finland, Italy and Spain, and will involve a total of 1,000 participants.

El objetivo de AI-Mind es desarrollar herramientas de diagnóstico inteligentes para predecir, en una fase temprana, quién tiene probabilidades de desarrollar demencia. El estudio se llevará a cabo en Noruega, Finlandia, Italia y España, y contará con un total de 1.000 participantes.

AI-MIND käyttää tekoälyä ihmisen aivojen toiminnan mallintamiseen. Tutkimuksen ja mallien avulla voidaan ymmärtää lievää kognitiivistä heikentymistä aiempaan paremmin ja luoda välineitä ennustaa ihmisten riskiä sairastua dementiaan.

AI-Mind leverages the opportunities offered by AI to develop innovative tools for the prediction, research and diagnosis of dementia. However, few AI technologies have been successfully implemented in clinical practice with proven benefits.

Liittymällä AI-Mind-uutiskirjeen tilaajaksi ja/tai mahdollisten kutsujen vastaanottajaksi, olette ymmärtänyt uutiskirjeen ja kutsujen tavoitteen, ja hyväksytte vastaanottavanne niitä antamaanne sähköpostiosoitteeseen.

AI-Mind will develop an “Intelligent diagnos-tics toolkit” for brain connectivity screening and dementia risk estimation in people with MCI containing two new artificial intelligence-based digital tools: the AI-Mind Connector and the AI-Mind Predictor. The AI-Mind Connector will identify dysfunctional brain networks (e.g.